{"id":"https://openalex.org/W2004707266","doi":"https://doi.org/10.1016/s1567-5688(10)70899-0","title":"MS398 THE INFLUENCE OF RAMIPRIL (AMPRILAN) ON THE INFLAMMATION MARKERS AND THE IMMEDIATE PROGNOSIS OF MYOCARDIAL INFARCTION","display_name":"MS398 THE INFLUENCE OF RAMIPRIL (AMPRILAN) ON THE INFLAMMATION MARKERS AND THE IMMEDIATE PROGNOSIS OF MYOCARDIAL INFARCTION","publication_year":2010,"publication_date":"2010-06-01","ids":{"openalex":"https://openalex.org/W2004707266","doi":"https://doi.org/10.1016/s1567-5688(10)70899-0","mag":"2004707266"},"language":"en","primary_location":{"id":"doi:10.1016/s1567-5688(10)70899-0","doi":"https://doi.org/10.1016/s1567-5688(10)70899-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(10)70899-0","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2004707266"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072982429","display_name":"Arkadiy L. Vertkin","orcid":"https://orcid.org/0000-0001-8975-8608","observed_orcids":["https://orcid.org/0000-0001-8975-8608"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Vertkin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5011002694","display_name":"\u0410. \u0421. \u0421\u043a\u043e\u0442\u043d\u0438\u043a\u043e\u0432","orcid":"https://orcid.org/0000-0002-8856-3638","observed_orcids":["https://orcid.org/0000-0002-8856-3638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Skotnikov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"2","first_page":"190","last_page":"190"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.875,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.875,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.03739999979734421,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.0203000009059906,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ramipril","display_name":"ramipril","score":1.0},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.8500000238418579},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9660000205039978},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.8100000023841858},{"id":"https://openalex.org/keywords/acute-myocardial-infarction","display_name":"acute myocardial infarction","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C2779888176","wikidata":"https://www.wikidata.org/wiki/Q412666","display_name":"Ramipril","level":3,"score":0.8984045386314392},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.7596191763877869},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6749095916748047},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6346634030342102},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6047108173370361},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5238345265388489},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1567-5688(10)70899-0","doi":"https://doi.org/10.1016/s1567-5688(10)70899-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(10)70899-0","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4245824069","https://openalex.org/W4301032963","https://openalex.org/W2078422683","https://openalex.org/W2037259968","https://openalex.org/W2049871913","https://openalex.org/W2143417962","https://openalex.org/W2038380438","https://openalex.org/W2023892054","https://openalex.org/W2076029600","https://openalex.org/W2364127399"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2016-06-24T00:00:00"}